Literature DB >> 5045468

Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.

W E Wick, D A Preston.   

Abstract

Three new cephalosporin antibiotics, prepared by substitution of heterocyclic groups on 7-aminocephalosporanic acid, possess certain desirable chemical or biological properties. All three compounds are active in vitro against a variety of gram-positive and gram-negative bacteria. Minimal inhibitory concentrations (MIC) of these bactericidal antibiotics were not significantly affected by changes in pH or NaCl content of nutrient broth, or by the use of different inoculum sizes. However, agar-dilution MIC values were generally two- to fourfold lower than the MIC values in comparable broth-dilution tests. Stability to cephalosporinase by two of the compounds extended their antibacterial spectra over cephalothin and cephaloridine to include strains of Enterobacter sp. and indole-positive Proteus sp. Binding to serum proteins of the new cephalosporins was intermediate between cephalothin and cephaloridine. Excellent concentrations of the antibiotics were attained in mouse blood, after subcutaneous administration of 20 mg per kg. In vitro biological characteristics of the antibiotics were verified by successful therapy of experimental mouse infections. Regression lines were calculated to show the correlation of agar-dilution MIC values with zones of inhibition by the disc testing procedure. Because each of the three new cephalosporins has certain advantageous properties over cephalothin and cephaloridine, additional toxicological and pharmacological data should be obtained for all three compounds.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5045468      PMCID: PMC444196          DOI: 10.1128/AAC.1.3.221

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Observations on the nature, distribution, and significance of cephalosporinase.

Authors:  P C FLEMING; M GOLDNER; D G GLASS
Journal:  Lancet       Date:  1963-06-29       Impact factor: 79.321

2.  Antipenicillinase serum: use in treatment of resistant staphylococcal infections in laboratory animals.

Authors:  W E WICK; D H HOLMES; W S BONIECE
Journal:  Antibiot Chemother (Northfield)       Date:  1960-02

3.  [A new technic for study of the bactericidal effect of combined antibiotics: transfer on cellophane].

Authors:  Y CHABBERT
Journal:  Ann Inst Pasteur (Paris)       Date:  1957-09

4.  Committee Reports: Committee on Evaluation and Standards: REPORT OF THE CHAIRMAN, 1967.

Authors:  E Neter; T A Olson; E Press; E M Reese; K T Roark; I M Rosenstock; J H Steele; B F Mattison; A G Baker; P Bierman; D H Byers; R L Huenemann; E J Kilcawley; A D Langmuir; F E Moore; M S Hilbert
Journal:  Am J Public Health Nations Health       Date:  1968-02

5.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

6.  Behaviour of "methicillin hetero-resistant" staphylococci to cephaloridine.

Authors:  Y A Chabbert
Journal:  Postgrad Med J       Date:  1967-08       Impact factor: 2.401

7.  Cefazolin, a new semisynthetic cephalosporin antibiotic. I. Synthesis and chemical properties of cefazolin.

Authors:  K Kariyone; H Harada; M Kurita; T Takano
Journal:  J Antibiot (Tokyo)       Date:  1970-03       Impact factor: 2.649

8.  Cefazolin, a new semisynthetic cephalosporin antibiotic. IV. Antigenicity of cefazolin and its cross reactivity with benzylpenicillin, ampicillin and cephaloridine.

Authors:  Y Mine; M Nishida; S Goto; S Kuwahara
Journal:  J Antibiot (Tokyo)       Date:  1970-04       Impact factor: 2.649

9.  Cephalothin, a new cephalosporin with a broad antibacterial spectrum. I. In vitro studies employing the gradient plate technique.

Authors:  C W GODZESKI; G BRIER; D E PAVEY
Journal:  Appl Microbiol       Date:  1963-03

10.  Factors influencing in vitro susceptibility to the cephalosporins and clinical trial of an oral cephalosporin, cephaloglycin.

Authors:  A R Ronald; M Turck
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966
View more
  38 in total

1.  Dosage adjustments of cefazolin according to the pharmacokinetics of this new cephalosporin.

Authors:  J Lavillaureix; J M Brogard; M Pinget; F Ledoux
Journal:  Infection       Date:  1975       Impact factor: 3.553

2.  Pharmacokinetic interpretation of blood levels and urinary excretion data for cefazolin and cephalothin after intravenous and intramuscular administration in humans.

Authors:  E S Rattie; L J Ravin
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

3.  Pharmacological studies with cefamandole in human volunteers.

Authors:  B R Meyers; B Ribner; S Yancovitz; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

4.  A new cephalosporin with a dual mode of action.

Authors:  C H O'Callaghan; R B Sykes; S E Staniforth
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

5.  Stable antibiotic sensitivity disks.

Authors:  R R Pfeiffer; G L Engel; D Coleman
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

6.  Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.

Authors:  E C Ernst; S Berger; M Barza; N V Jacobus; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

7.  Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

8.  In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.

Authors:  N Matsubara; S Minami; T Muraoka; I Saikawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

9.  Cephanone: in vitro antibacterial activity and pharmacology in normal human volunteers.

Authors:  B R Meyers; S Z Hirschman; P Nicholas
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

10.  Comparative study of seven cephalosporins: susceptibility to beta-lactamases and ability to penetrate the surface layers of Escherichia coli.

Authors:  M H Richmond; S Wotton
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.